Koninklijke Philips - PHG Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 2
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$21.07
▲ +0.35 (1.69%)

This chart shows the closing price for PHG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Koninklijke Philips Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHG

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for Koninklijke Philips in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $21.07.

This chart shows the closing price for PHG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 2 investment analysts is to hold stock in Koninklijke Philips. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
11/4/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
2/2/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
5/3/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
8/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
10/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
1/28/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
3/28/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
4/27/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/7/2024BNP ParibasDowngradeOutperform ➝ UnderperformLow
7/12/2023The Goldman Sachs GroupInitiated CoverageBuyLow
7/7/2023CitigroupBoost Target€19.00Low
4/25/2023Societe GeneraleUpgradeSell ➝ HoldLow
3/7/2023Sanford C. BernsteinInitiated CoverageMarket PerformLow
1/31/2023Societe GeneraleDowngradeHold ➝ SellLow
1/17/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight€17.00 ➝ €16.00Low
1/17/2023UBS GroupDowngradeNeutral ➝ SellLow
1/10/2023BarclaysLower TargetOverweight ➝ Overweight€19.00 ➝ €18.50Low
11/1/2022JPMorgan Chase & Co.Lower Target€18.80 ➝ €10.90Low
10/26/2022BarclaysLower Target€38.00 ➝ €19.00Low
10/25/2022HSBCDowngradeHold ➝ ReduceLow
10/18/2022Morgan StanleyInitiated CoverageEqual WeightLow
10/18/2022Jefferies Financial GroupDowngradeBuy ➝ HoldN/A
10/14/2022Deutsche Bank AktiengesellschaftDowngradeHold ➝ SellLow
10/13/2022Societe GeneraleDowngradeBuy ➝ HoldLow
10/13/2022Oddo BhfDowngradeOutperform ➝ Neutral€17.00Low
10/7/2022UBS GroupLower TargetNeutral ➝ Neutral€16.40 ➝ €16.10Low
10/6/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold€22.00 ➝ €18.00Low
9/12/2022Societe GeneraleUpgradeHold ➝ Buy€22.40 ➝ €21.00Low
9/5/2022UBS GroupUpgradeSell ➝ NeutralLow
7/28/2022BarclaysLower Target€45.00 ➝ €39.00Low
7/27/2022JPMorgan Chase & Co.Lower TargetUnderweight ➝ Underweight€21.30 ➝ €18.80Low
7/26/2022UBS GroupLower TargetSell ➝ Sell€17.00 ➝ €16.00Low
7/25/2022Societe GeneraleDowngradeBuy ➝ HoldLow
7/5/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold€25.00 ➝ €24.00N/A
7/5/2022BarclaysLower TargetOverweight ➝ Overweight€45.50 ➝ €45.00N/A
6/29/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold€30.00 ➝ €25.00Low
6/16/2022UBS GroupDowngradeNeutral ➝ SellLow
5/25/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight€26.50 ➝ €21.30Low
4/26/2022JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral€29.20 ➝ €26.50Low
3/28/2022Credit Suisse GroupLower Target€32.50 ➝ €31.00High
3/28/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold€35.00 ➝ €30.00High
3/23/2022AlphaValueDowngradeBuyMedium
1/26/2022Credit Suisse GroupLower TargetNeutral ➝ Neutral€42.00 ➝ €32.50Low
1/21/2022ING GroupDowngradeBuy ➝ HoldLow
1/20/2022Jefferies Financial GroupDowngradeBuy ➝ HoldLow
1/14/2022BarclaysLower Target€51.50 ➝ €46.00High
1/14/2022HSBCUpgradeHold ➝ BuyLow
1/12/2022CitigroupDowngradeBuy ➝ NeutralHigh
1/10/2022Deutsche Bank AktiengesellschaftLower Target€36.00 ➝ €35.00Low
12/1/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldMedium
10/27/2021BarclaysReiterated RatingOverweightLow
10/25/2021Credit Suisse GroupReiterated RatingNeutralLow
10/19/2021JPMorgan Chase & Co.Reiterated RatingNeutralHigh
10/19/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldLow
9/10/2021BarclaysReiterated RatingOverweightLow
9/8/2021Jefferies Financial GroupInitiated CoverageBuyLow
8/31/2021ING GroupUpgradeHold ➝ BuyLow
8/4/2021Morgan StanleyReiterated RatingOverweightLow
7/28/2021UBS GroupReiterated RatingBuyLow
7/28/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldLow
7/28/2021Bank of AmericaDowngradeBuy ➝ NeutralLow
7/28/2021Oddo BhfUpgradeNeutral ➝ OutperformLow
7/8/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldLow
6/29/2021BarclaysReiterated RatingOverweightLow
6/21/2021HSBCDowngradeBuy ➝ HoldLow
4/29/2021Berenberg BankReiterated RatingBuyLow
4/28/2021Credit Suisse GroupReiterated RatingNeutralLow
4/27/2021UBS GroupReiterated RatingBuyLow
3/23/2021BarclaysReiterated RatingOverweightMedium
3/18/2021JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightMedium
1/26/2021Credit Suisse GroupReiterated RatingNeutralHigh
1/26/2021JPMorgan Chase & Co.Reiterated RatingNeutralHigh
1/26/2021UBS GroupReiterated RatingBuyHigh
1/20/2021Berenberg BankReiterated RatingBuyLow
1/19/2021JPMorgan Chase & Co.Reiterated RatingNeutralLow
11/12/2020Berenberg BankReiterated RatingBuyLow
10/29/2020Morgan StanleyReiterated RatingOverweightLow
10/21/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
10/20/2020UBS GroupReiterated RatingBuyLow
10/20/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
10/2/2020UBS GroupReiterated RatingBuyLow
9/23/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
9/23/2020BarclaysReiterated RatingOverweightLow
9/3/2020JPMorgan Chase & Co.Reiterated RatingNeutralHigh
9/1/2020UBS GroupReiterated RatingBuyMedium
8/27/2020Societe GeneraleDowngradeSellLow
7/28/2020Societe GeneraleInitiated CoverageBuyMedium
7/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
7/9/2020Morgan StanleyReiterated RatingOverweightLow
6/22/2020BarclaysReiterated RatingOverweightLow
4/22/2020Morgan StanleyReiterated RatingOverweightLow
4/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralMedium
4/19/2020Kepler Capital MarketsReiterated RatingHoldHigh
4/7/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
3/23/2020DZ BankReiterated RatingHold ➝ BuyHigh
3/23/2020UBS GroupReiterated RatingBuyLow
3/10/2020Kepler Capital MarketsReiterated RatingHoldMedium
2/10/2020UBS GroupReiterated RatingBuyLow
1/21/2020Roth CapitalReiterated RatingBuyMedium
1/13/2020Bank of AmericaBoost TargetBuy$45.00 ➝ $51.00Low
12/6/2019Morgan StanleyUpgradeEqual Weight ➝ OverweightMedium
10/28/2019Berenberg BankReiterated RatingBuyMedium
10/7/2019Berenberg BankReiterated RatingBuyLow
8/29/2019JPMorgan Chase & Co.Reiterated RatingNeutralLow
7/30/2019CitigroupInitiated CoverageBuy ➝ BuyLow
(Data available from 4/28/2019 forward)

News Sentiment Rating

0.43 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 5 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
10/1/2023
  • 17 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 4 very negative mentions
10/31/2023
  • 11 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/30/2023
  • 5 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
12/30/2023
  • 5 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/29/2024
  • 16 very positive mentions
  • 21 positive mentions
  • 9 negative mentions
  • 1 very negative mentions
2/28/2024
  • 8 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/29/2024
  • 13 very positive mentions
  • 24 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
4/28/2024

Current Sentiment

  • 13 very positive mentions
  • 24 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Koninklijke Philips logo
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Read More

Today's Range

Now: $21.07
Low: $20.96
High: $21.15

50 Day Range

MA: $20.43
Low: $19.85
High: $21.56

52 Week Range

Now: $21.07
Low: $17.75
High: $24.27

Volume

924,186 shs

Average Volume

876,154 shs

Market Capitalization

$19.57 billion

P/E Ratio

N/A

Dividend Yield

4.39%

Beta

0.88

Frequently Asked Questions

What sell-side analysts currently cover shares of Koninklijke Philips?

The following equities research analysts have issued research reports on Koninklijke Philips in the last year: BNP Paribas, Citigroup Inc., StockNews.com, The Goldman Sachs Group, Inc., and TheStreet.
View the latest analyst ratings for PHG.

What is the current price target for Koninklijke Philips?

0 Wall Street analysts have set twelve-month price targets for Koninklijke Philips in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Koninklijke Philips in the next year.
View the latest price targets for PHG.

What is the current consensus analyst rating for Koninklijke Philips?

Koninklijke Philips currently has 1 sell rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PHG, but not buy more shares or sell existing shares.
View the latest ratings for PHG.

What other companies compete with Koninklijke Philips?

Other companies that are similar to Koninklijke Philips include Hologic, GE HealthCare Technologies, Illumina, Genmab A/S and STERIS. Learn More about companies similar to Koninklijke Philips.

How do I contact Koninklijke Philips' investor relations team?

Koninklijke Philips' physical mailing address is PHILIPS CENTER AMSTELPLEIN 2, AMSTERDAM P7, 1096 BC. The technology company's listed phone number is (120) 597-7777 and its investor relations email address is [email protected]. The official website for Koninklijke Philips is www.philips.com. Learn More about contacing Koninklijke Philips investor relations.